Angiogenesis inhibition on glioblastoma multiforme cell lines (U-87 MG and T98G) by AT-101

This study showed that AT-101 suppress VEGF on protein levels at U-87 MG and T98G cell lines and showed AT-101 might be a promising targeted agent in GBM treatment.